Beate Rohde | Head Development Clinical Pharmacology Bayer Pharma
2005 Board certification as Clinical Pharmacologist
Professional Experience (incl. Memberships)
1992 - 1993 Internship (Internal Medicine)
1993 - 1995 Scientist, Clinical Pharmacology, University of Rostock
1995 - 2001 Scientist, Clinical Pharmacology, Schering AG, Berlin
Fields of responsibility:
- Clinical Pharmacology Lead responsible for several early/ late
development projects (e.g. antihormones, stroke, pulmonary
hypertension)
- Study Manager, Investigator in many phase I studies
2001 - 2003 Head of Monitoring and CRO-Management,
Clinical Pharmacology, Schering AG, Berlin
Fields of responsibility:
- Clinical Pharmacology Lead in development projects
(e.g. contraception, menopause management)
- Head of CRA group, built up of CRO Management within CP
2003 – 2005 Head of Study Management, Clinical Pharmacology, Schering AG
Fields of responsibility:
- Pharmacodynamic Expertise / Study Management for all early
development projects within therapeutic areas Womens
Healthcare (WH), Diagnostic Imaging (DI) and Specialized
Therapeutics (STH)
- Medical Expertise for ClinPharm studies / Study Management
within late-stage development projects
2005 - 2010 Head of Clinical Pharmacodynamics (WH/DI/STH),
Clinical Pharmacology
Schering AG and Bayer Schering Pharma AG, Berlin
Fields of responsibility:
- Pharmacodynamic/Medical Expertise for all early development
projects within therapeutic areas WH, DI, STH
including an inhouse investigational CP- Unit
- Pharmacodynamic/Medical Expertise for ClinPharm part during
late-stage development projects
Share this
Appearances at this years' conference:
Thursday 24 May 2012- Day Two
@ 16.00
Making accurate risk assessment of FIH clinical studies
- Risk mitigation by careful design and conduct of FiH studies
- Choice of study population: safety considerations vs. exploration of treatment effects
› Beate Rohde, Head Development Clinical Pharmacology, Bayer Pharma